| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |